Reports
Sale
Global Ablation Technology Market Share, Forecast: By Technology: Radiofrequency Devices, Laser/Light Ablation, Ultrasound Devices, Cryoablation Devices, Other Devices; By Applications: Cancer Treatment, Cardiovascular Disease Treatment, Ophthalmologic Treatment, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Ablation Technology Market Outlook
The global ablation technology market size attained a value of 6.05 billion in 2023. The market is expected to grow at a CAGR of 9.8% between 2024 and 2032, reaching almost 14.0 billion by 2032.
Ablation Technology: Introduction
Ablation technology is used in ablation therapy which is a minimally invasive tissue to destroy (ablate) an abnormal tissue present in any condition. The abnormal tissue can be destroyed through various techniques, including heat (radiofrequency), cold (cryoablation), chemicals, or lasers. It is done via a probe that is inserted through the skin, energy beams, or flexible tubes (catheters) inserted through an artery. It is mostly guided with the help of imaging techniques.
Ablation technologies find wide application in multiple domains ranging from surgery to radiation therapies. It causes less pain and allows a shorter recovery span as well as same day discharge in patients.
Global Ablation Technology Market Analysis
The worldwide prevalence of atrial fibrillation has approximately increased by 20%, affecting 0.51% of the worldwide population. As medications do not always work to reduce the symptoms in many patients, the cardiac practitioners have diverted towards cardiac ablation for the treatment. This is one of the major drivers for ablation technology market demand.
Consequently, there has been active clinical research to bring new advances to the field. For instance, the Heart Rhythm Society announced the efficacy of pulsed field ablation, an alternative to conventional thermal treatment. This is a non-thermal ablation technology that utilizes electrical pulses to cause electroporation and induce cardiac cell death. In addition, in May 2024, Abbott’s TactiFlex™ Ablation Catheter, got approved by the FDA. This device can lead to safer and less time-consuming procedures. Hence, we can anticipate market growth in the ablation technology in the upcoming years.
Emerging technologies like microwave ablation (MWA), cryoablation, radiofrequency ablation (RFA) is also applied in oncological treatments. MWA and cryoablation are gradually growing as a stable alternative to surgical resection for non-small lung cancers, as MWA can control tumour progression while cryoablation extends a patient's survival span. The minimal invasiveness and low risk procedures indicate that the ablation technology market value is set to grow in the forecast period.
Global Ablation Technology Market Segmentation
Market Breakup by Technology
- Radiofrequency Devices
- Laser/Light Ablation
- Ultrasound Devices
- Cryoablation Devices
- Other Devices
Market Breakup by Applications
- Cancer Treatment
- Cardiovascular Disease Treatment
- Ophthalmologic Treatment
- Gynaecological Treatment
- Urological Treatment
- Cosmetic Surgery
- Others
Market Breakup by End User
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Ablation Technology Market Overview
The North America, especially the United States, has dominated the ablation technology market share in the historical period. The presence of healthcare industry pioneers has played a significant role in driving efficient technical advances for the patients. Currently, major industry leaders like Johnson and Johnson, Medtronic and Boston Scientific Corporation are waiting for their respective pulsed field ablation catheters to be approved by the FDA. Boston Scientific Corporation’s first-generation pulse field ablation device “Farapulse” has already been approved by the EU in 2021. It will fetch FDA’s approval by 2024 tentatively. Similarly, Medtronic’s “Pulse Select” and Johnson & Johnson’s “Varipulse” are in queue as well.
The ablation technology market growth will be swift in the Asia Pacific region owing to the emphasis on the development of a medical technology driven infrastructure. With the availability of affordable resources, it has been welcoming plenty of foreign investments as well. In addition, the geriatric population will be a significant aspect of market growth. It may lead to a boost in the number of surgical procedures where ablation techniques may be applied. Hence, the market will grow in the forecast period.
Global Ablation Technology Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott
- AngioDynamics, Inc.
- AtriCure, Inc.
- Boston Scientific Corporation
- BTG plc
- Conmed Corporation
- Johnson & Johnson
- Medtronic PLC
- Olympus Corporation
- Smith & Nephew PLC
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Ablation Technology Market Overview
3.1 Global Ablation Technology Market Historical Value (2017-2023)
3.2 Global Ablation Technology Market Forecast Value (2024-2032)
4 Global Ablation Technology Market Landscape
4.1 Global Ablation Technology: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Ablation Technology: Product Landscape
4.2.1 Analysis by Technology
4.2.2 Analysis by Applications
5 Global Ablation Technology Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Ablation Technology Market Segmentation
6.1 Global Ablation Technology Market by Technology
6.1.1 Market Overview
6.1.2 Radiofrequency Devices
6.1.3 Laser/Light Ablation
6.1.4 Ultrasound Devices
6.1.5 Cryoablation Devices
6.1.6 Other Devices
6.2 Global Ablation Technology Market by Applications
6.2.1 Market Overview
6.2.2 Cancer Treatment
6.2.3 Cardiovascular Disease Treatment
6.2.4 Ophthalmologic Treatment
6.2.5 Gynecological Treatment
6.2.6 Urological Treatment
6.2.7 Cosmetic Surgery
6.2.8 Others
6.3 Global Ablation Technology Market by End User
6.3.1 Market Overview
6.3.2 Hospitals and Clinics
6.3.3 Ambulatory Surgical Centers
6.3.4 Others
6.4 Global Ablation Technology Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Ablation Technology Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Ablation Technology Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Ablation Technology Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Ablation Technology Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Ablation Technology Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Abbott
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 AngioDynamics, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 AtriCure, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Boston Scientific Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 BTG plc
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Conmed Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Johnson & Johnson
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Medtronic PLC
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Olympus Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Smith & Nephew PLC
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 6.05 billion in 2023, driven by the preference of treating diseases like atrial fibrillation and cancer with ablation therapy.
The market is anticipated to grow at a CAGR of 9.8% during the forecast period of 2024-2032, likely to reach a market value of USD by 14.0 billion by 2032.
With the incidence of chronic illnesses, the preference for minimally invasive procedures that are efficient and have a shorter recovery span has grown, hence, the market demand for ablation technology has increased.
Several first-generation pulse field ablation devices like “Farapulse” by Boston Scientific Corporation, “Pulse Select” by Medtronic and “Varipulse” by Johnson & Johnson are the upcoming devices waiting for FDA approval. Microwave ablation (MWA), cryoablation, radiofrequency ablation (RFA) is among the emerging technologies applied in oncological treatments as well.
It include radiofrequency devices, laser/light ablation, ultrasound devices, and cryoablation devices, among other devices.
Ablation technology finds wide application in cancer, cardiovascular disease, ophthalmologic, gynaecological, urological treatment, and cosmetic surgery, among others.
End users include hospitals and clinics and ambulatory surgical centers, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Key players involved in the market are Abbott, AngioDynamics, Inc., AtriCure, Inc., Boston Scientific Corporation, BTG plc, Conmed Corporation, Johnson & Johnson, Medtronic PLC, Olympus Corporation, and Smith & Nephew PLC.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER